showing the working

← Health care

VASO

VASO

Health care · fiscal year ending 2025-12-31 · pays no dividend

Through the investors’ lenses

0 of 2 cleared3 of 6 criteria

Each of these investors has said in public what they look at before buying. Click a name to see how this company measures up — a tick where it passes one of their tests, a cross where it does not.

Warren Buffett 2/3
MeasureVASOChecked against
Owner earningspositive
Return on equity5.3%US median 2.8%
Debt to equity0.01xUS median 0.57x
Operating margin-3.2%US median 3.1%

Passes 2 of 3. These are the measures Warren Buffett published, applied to VASO’s own figures — their criteria, not their view of this company. What he looks at, and why →

Benjamin Graham 1/3
MeasureVASOChecked against
Current ratio1.59x2.00x published
Long-term debt to working capital0.01x1.00x published
Positive earnings, ten years running6 yrs10 published

Passes 1 of 3. These are the measures Benjamin Graham published, applied to VASO’s own figures — their criteria, not their view of this company. What he looks at, and why →

Two of nineteen investors are read on every page, free. Investor reads fourteen, Analyst all nineteen.

The business

MeasureVASOMedianFormula
Return on equity5.3%2.8%Net income ÷ shareholders’ equity
Return on capital employed-9.7%5.1%Operating income ÷ (equity + total debt)
Owner earnings$1.09mNet income + depreciation & amortisation − capital expenditure
Free cash flow$7.57mOperating cash flow − capital expenditure
Operating margin-3.2%3.1%Operating income ÷ revenue
Net margin1.8%2.0%Net income ÷ revenue
Debt to equity0.01x0.57xTotal debt ÷ shareholders’ equity
Interest cover1.01xOperating income ÷ interest expense
Current ratio1.59x1.69xCurrent assets ÷ current liabilities
Long-term debt to working capital0.01x1.09xLong-term debt ÷ (current assets − current liabilities)
Cash conversion5.91x1.58xOperating cash flow ÷ net income
Accruals-8.7%-4.7%(Net income − operating cash flow) ÷ total assets

Ten years of it

The same measures, for every year the filings support. One year is a fact; a row is a business.

Measure2025202420232022202120202019201820172016Median
Return on equity5.3%3.4%17.9%51.2%55.0%7.0%-8.9%-81.9%-49.6%6.4%5.3%
Return on capital employed-9.7%1.0%15.6%29.2%25.4%4.6%4.7%-24.7%-21.2%7.0%4.6%
Operating margin-3.2%0.3%5.2%8.1%3.7%1.1%0.8%-5.0%-5.3%2.2%0.8%
Net margin1.8%1.1%5.9%14.2%8.1%0.5%-0.5%-5.0%-6.2%1.1%1.1%
Debt to equity0.01x0.00x0.00x0.00x0.00x2.31x1.89x2.31x0.97x0.74x0.01x
Current ratio1.59x1.47x1.50x1.30x0.90x0.70x0.73x0.54x0.76x0.98x0.90x
Cash conversion5.91x3.45x1.10x1.28x1.28x16.58x6.36x3.45x

This company pays no dividend, so there is no payout ratio to compute and no coverage rating. Every figure above comes from its own SEC filing. How these are computed.

Who else looks like this

Every figure above is computed from VASO’s own filing, and every company here is measured the same way. Screen all of them on any of these twelve measures, or on the rules two investors published — free, and nothing you screen leaves your browser.

Screen every company →